Home LiteratureArticle Details
PMID: 7933988 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo.

Laboratory investigation; a journal of technical methods and pathology ·Vol. 71 ·No. 3 ·1994-09-00 ·Pages 374-9

Minchenko A, Bauer T, Salceda S, Caro J

Abstract

Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen with potent angiogenic properties. In tumors, VEGF has been localized to the most necrotic and ischemic areas of the tissues, suggesting that local hypoxia is a potent inducer of VEGF production. Initial experiments in vitro confirmed the stimulatory effect of hypoxia on VEGF expression. The extent of this response and the mechanisms involved in oxygen sensing are poorly characterized. Confluent monolayers of malignant cell lines or primary cultures of fibroblast or endothelial cells were exposed to hypoxia or incubated with either cobalt chloride, a stimulator of erythropoietin gene expression, or sodium azide, an inhibitor of oxydative phosphorylation. VEGF expression was analyzed by Northern blot or RNase protection assays. The expression VEGF in vivo was studied in animals subjected to hypobaric hypoxia or functional anemia. Hypoxia greatly stimulated VEGF expression in tumor cell lines and primary fibroblast cultures. Endothelial cells, that expressed very low constitutive levels of VEGF, were resistant to hypoxic stimulation. RNase protection analysis showed that hypoxia primarily stimulated the induction of smaller and medium VEGF isoforms, i.e., the same ones expressed under normal conditions. The stimulatory effect of hypoxia on VEGF could be reproduced in vitro by cobalt chloride but not with sodium azide. In vivo, both hypoxia and anemia were found to be potent inducers of VEGF expression in several organs including heart, brain, liver, kidney, and muscle. As in vitro, cobalt was also found to be a potent stimulator of VEGF in vivo. Hypoxia is a potent inducer of VEGF expression in malignant as well as normal cultured cells. It is also a stimulator of VEGF expression in vivo. The VEGF gene appears to respond to hypoxia like the erythropoietin gene, and the mechanism of oxygen sensing probably is mediated by a heme-containing protein.

MeSH Terms
Anemia/metabolism Animals Cells, Cultured Cobalt/pharmacology Endothelial Growth Factors/genetics,metabolism Endothelium, Vascular/cytology,metabolism Fibroblasts/metabolism Gene Expression Hypoxia/metabolism Isomerism Lymphokines/genetics,metabolism Male Nucleic Acid Hybridization RNA, Messenger/metabolism Rats Rats, Wistar Ribonucleases Tissue Distribution Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Lymphokines RNA, Messenger Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Cobalt Ribonucleases cobaltous chloride
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Minchenko A
Department of Medicine, Cardeza Foundation for Hematologic Research, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Bauer T
Salceda S
Caro J
Article Info
Journal
Laboratory investigation; a journal of technical methods and pathology
Abbr.
Lab Invest
ISSN
0023-6837
Published
1994-09-00
Pages
374-9
Language
English
Region
United States
NLM ID
0376617
Subset
IM
Grants
NIDDK NIH HHS · NIDDK R01 DK 34642 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com